FIDIA Farmaceutici to Attend the IMCAS World Congress 2016 in Paris

An opportunity to showcase FIDIA's unique products in the dermo-aesthetic area

FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based products, will be present at the IMCAS World Congress, January 28-31, 2016 at the Palais des Congrès in Paris (France).

Created for cosmetic dermatologists and aesthetic plastic surgeons by a scientific board made up of internationally renowned practitioners, IMCAS Annual World Congress is a CME accredited conference that offers a world-class four-day learning experience at the interface between plastic surgery and dermatology.

Over 6 000 attendees are expected this year, as well as 400 speakers and 165 exhibitors

The Company will be present in the Exhibition area with booth C1.


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine